Thomas K. Equels, CEO & President at AIM ImmunoTech Inc. (AIM), bought 3,937,008 shares at $0.03 ($118K) on 2025-04-11, disclosed to the SEC on 2025-04-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.03 | 1,968,504 | $59K | 50.0% |
| 2 | $0.03 | 1,968,504 | $59K | 50.0% |
| Total | $0.03 avg | 3,937,008 | $118K | 100% |
| Filing → |
| AIM | BUY | 2026-09-16 | $5K | — | Filing → |
| AIM | BUY | 2026-09-15 | $1K | — | Filing → |
| AIM | BUY | 2025-06-16 | $824 | — | Filing → |